Navigation Links
Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Date:7/21/2009

MOUNTAIN VIEW, Calif., July 21 /PRNewswire/ -- Howard Rosenberg, M.D., a board-certified plastic surgeon and Medical Director at Accent on Aesthetics Plastic Surgery Medical Center, has selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines. Dr. Rosenberg has treated more than fifty patients with Artefill due to its proven success and effectiveness for the long lasting correction of wrinkles.

Dr. Rosenberg commented, "Artefill is a product we have consistently recommended to our patients who are looking for a dermal filler that lasts longer and doesn't require repeat injections. We believe we have had great success with the product over the past few years as it's easy to administer and the patient experience is similar to temporary fillers on the market today."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide the support the skin needs for long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Artefill is only offered by a select group of physicians in Northern California and is not available at all physician offices. Dr. Rosenberg is one of the company trained and select few company sponsored physicians who has the skills and experience needed to administer the produc
'/>"/>

SOURCE Accent on Aesthetics Plastic Surgery Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
2. New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults
3. Plastic Surgeons Warn of Malnutrition in Body Contouring Patients
4. Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
5. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
6. Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
7. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
8. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
9. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
10. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
11. Shoulder Surgery Doesnt Prevent Return to Sports

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...FirstCall/--EchoTherapeutics,Inc.(OTCBulletinBoard...)tCGMSystemasanon-invasive,wireless,transdermalcon...TM)SkinPrepSystemfortransdermaldrugdelivery,announ...xecutiveOfficer,willpresentatthe13thAnnualBiotecha...eNewYorkSocietyofSecuritiesAnalysts,at2:05onDecemb...
(Date:11/24/2009)...stCall/--ZimmerHoldings,Inc.(NYSE: ZMH ;SIX:ZMH)an...perJaffrayHealthCareConferenceinNewYork,NewYork,on...ebcastofthepresentationcanbeaccessedviaZimmer,sInv... .Thewebcastwillbearchivedforreplayfollowingthecon...27andheadquarteredinWarsaw,Indiana,Zimmerdesigns,d...
(Date:11/24/2009)...all/--OptimerPharmaceuticals,Inc.(Nasdaq: OPTR )is...hCareConferenceatTheNewYorkPalaceinNewYorkCityonDe...tp://www.newscom.com/cgi-bin/prnh/20090413/LA97352...llbeaccessibleontheInvestorspageoftheCompany,swebs...tationwillbeavailableatthesamelocationfor30daysfol...
Breaking Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2PLC Systems Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6134 1PLC Systems Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6134 2PLC Systems Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6134 3Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 1Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 2Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 3Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 4Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 5Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 6Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 7Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 8Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 9Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 10Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 1Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 2Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 3
...--Jul 6, 2007 - Neurologix, Inc.,(OTCBB:NRGX), a b...,innovative gene therapies for the brain and centr...y will present at the Third Annual,C.E. Unterberg ...10, 2007 at 4:30 pm ET at The Mandarin Oriental Ho...ficer John Mordock will discuss,Neurologix,s busin...
...--Jul 5, 2007 - Array BioPharma Inc.,(Nasdaq: ARRY...,Robert E. Conway, will speak at the C.E Unterbeg...New York City. The public is,welcome to participat... BioPharma website. -0-, ,Event: C.E Unte...: Robert E. Conway, Chief Executive Officer, ...
Other Medicine Technology:
(Date:11/24/2009)...rm Software will be Offered Initially to the Acade... (PRWEB) -- Ziosoft®, Inc. a leader in ad...ical imaging, is offering its new zioTerm™ b...rch communities. The Windows®-based software ...ging data from CT, MR, PET, ultrasound and X-ray o...
(Date:11/24/2009)...-type device to be coupled with Stem Cell Therapy....November 24, 2009 -- Entest Biomedical, Inc. (OT...ions with a manufacturer of lasers regarding the d...ll be owned by Entest and used in conjunction with...oped by Entest. These therapies are aimed at incre...
(Date:11/24/2009)...n Shoulder experts offer seminar series, new ways ... relief to millions of sufferers. , ... One-To-Zero (OTZ) Health Education Systems ( www....rozen Shoulder Syndrome Diagnosis & Treatment...ars begin at noon Friday and end at noon Sunday wi...
(Date:11/24/2009)...al Tips to Get a Leg Up From the American Podiatri...ethesda, Md. (Vocus) November 24, 2009 -- The aver...mdash;but that number dramatically increases durin...rs alike continue making their holiday travel plan...ear the brunt of aches and pains while on the road...
(Date:11/24/2009)...ire-FirstCall/--USFarms,Inc.,(PinkSheets:USFM)adiv...tsispleasedtoannounceithasreceivedformalcertificat...foritsAloe365(TM)Juiceproduct. ,, YanSkwara,CEO...atwehavecompletedthecertificationprocesswiththeAme...uice.TheprimarygoaloftheAVAistoprovideawidelyrecog...
Breaking Medicine News(10 mins):Health News:Ziosoft Releases Free zioTerm Basic 2D/3D Software Application 2Health News:Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 3Health News:Keep Holiday Travel Foot-Friendly 2Health News:Keep Holiday Travel Foot-Friendly 3Health News:US Farms, Inc. Receives American Vegetarian Association Certification Approval for Aloe365(TM) Juice Product 2
...re on a three-day visit to see an NGO's activities...and child health.// The star of such thrille...h Crimes" will be visiting the Rajasthan capital a...assador for YouthAIDS, an education and prevention...
...asis can lead to male infertility, according to a ...he effect was found// to be reversible in 50 % of ...ed by a San Francisco urologist who analyzed data ... study are reported in the March-April 2007 issue ...
... suggests a new study.// Earlier studies hav...n. Now William Killgore and colleagues at the Walt...g, Maryland, US, studied 26 healthy adults, all of...ng processes that depend heavily on emotion, said ...
...ly to find themselves with lower cholesterol, part... research in the Journal of Epidemiology and Commu... after the age of 15 boosted cholesterol levels, t...sample of 5362 people born in one week of March in...
...ed medical practice that an antiretroviral drug wi...s safe to use// on its own in patients co-infected...nt with entecavir leads to cross-resistance to oth...e against HIV - it breeds resistance rapidly, desp...
... create part-animal and part-human only for resear...his was announced by the health minister Caroline ...ility treatment and embryo research. Permissio...hing from rabbit to cow to pig to sheep. This cybr...
Other Medicine News:Health News:Want a Baby? No Hot Baths Please ! 2Health News:Want a Baby? No Hot Baths Please ! 3Health News:Widely Used Hepatitis B Drug Spurs HIV Drug Resistance 2Health News:Widely Used Hepatitis B Drug Spurs HIV Drug Resistance 3
Needle Tip Electrode
Autorefractometer Accuref 8001
VISUTRON 900+
Acri.pur
Medicine Products: